Siemens expand its Walpole, Mass. Laboratory Diagnostic manufacturing facility

Siemens will invest $300M over the next four years

15-Dec-2016 - USA

Siemens Healthineers will invest around $300 million in its Walpole, Mass. laboratory diagnostics manufacturing and research and development facility.

"The expansion of the Walpole facility fits into the strategic growth plans for the company and allows us to increase our manufacturing footprint in the United States, the largest healthcare market in the world," said Bernd Montag, Chief Executive Officer, Siemens Healthineers. "The laboratory instruments and reagents developed and manufactured at the Siemens Healthineers Walpole facility impact patients and healthcare providers across the globe. "The Walpole facility currently employs more than 700 employees and is the main manufacturing facility for assays that run on the ADVIA® Centaur family of immunoassay instruments, and for consumables for its molecular and blood gas testing instruments. The facility will also manufacture assays to run on the immunoassay module of the AtellicaTM Solution, which is currently in development. R&D efforts at the site bring new tests to the diagnostics market to help physicians diagnose and treat disease.

"With a 37-year history of manufacturing products in Walpole, we saw an opportunity to leverage the local talent in the community to further our growth and expansion plans," said Franz Walt, President, Laboratory Diagnostics, Siemens Healthineers.

The company plans to upgrade and expand its existing 500,000 sq. ft. complex. Renovations to the existing facility will begin in the coming weeks. The expansion—which will include manufacturing, warehouse, office and lab space—is set to begin in the summer. Siemens Healthineers is committed to creating at least 400 positions. The company anticipates that it may ultimately create up to as many as 700 new permanent jobs to bring the total employment at the site to between 1,300 and 1,600 by 2026. These employees will join the 46,000 Siemens Healthineers around the world who enable healthcare providers to deliver excellent patient care.

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 whitepaper
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 whitepaper